Mitsugu Shimobayashi

Mitsugu Shimobayashi

Auto-generated profile, based on publicly available information

Mitsugu Shimobayashi

Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2014 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
MSMitsugu Shimobayashi
Mitsugu Shimobayashi
MHMichael N. Hall
Michael N. Hall

15 March 2013 in Science
Verified
Journal Article
Closed access
PDF file
ARAaron M. Robitaille
Aaron M. Robitaille
SCStefan Christen
Stefan Christen
MSMitsugu Shimobayashi
Mitsugu Shimobayashi
MCMarion Cornu
Marion Cornu
LFLuca L. Fava
Luca L. Fava
MHMichael N. Hall
Michael N. Hall
Coordinating Metabolism: Growth factors help to coordinate metabolism with growth in part by stimulating the activity of the protein kinase mTORC1 (mechanistic target of rapamycin complex 1). Ben-Sahra et al. (p. 1323 , published online 21 February) and Robitaille et al. (p. 1320 , published online 21 February) independently identified a key target of mTORC1—carbamolyl-phosphate synthase 2, or CAD, the rate-limiting enzyme for de novo synthesis of pyrimidines. Metabolomic profiling and phosphoproteomic analyses of normal cells and cells lacking signaling by mTORC1 converged on CAD as a key point at which growth-promoting signals also ramp up production of nucleic acids.

12 March 2018 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MSMitsugu Shimobayashi
Mitsugu Shimobayashi
VAVerena Albert
Verena Albert
BWBettina Woelnerhanssen
Bettina Woelnerhanssen
IFIrina C. Frei
Irina C. Frei
DWDiana Weissenberger
Diana Weissenberger
MHMichael Hall
Michael Hall
Obesity is a major risk factor for insulin resistance and type 2 diabetes. In adipose tissue, obesity-mediated insulin resistance correlates with the accumulation of proinflammatory macrophages and inflammation. However, the causal relationship of these events is unclear. Here, we report that obesity-induced insulin resistance in mice precedes macrophage accumulation and inflammation in adipose tissue. Using a mouse model that combines genetically induced, adipose-specific insulin resistance (mTORC2-knockout) and diet-induced obesity, we found that insulin resistance causes local accumulation of proinflammatory macrophages. Mechanistically, insulin resistance in adipocytes results in production of the chemokine monocyte chemoattractant protein 1 (MCP1), which recruits monocytes and activates proinflammatory macrophages. Finally, insulin resistance (high homeostatic model assessment of insulin resistance [HOMA-IR]) correlated with reduced insulin/mTORC2 signaling and elevated MCP1 production in visceral adipose tissue from obese human subjects. Our findings suggest that insulin resistance in adipose tissue leads to inflammation rather than vice versa.

11 December 2015 in Cell Research
Verified
Journal Article
Closed access
MSMitsugu Shimobayashi
Mitsugu Shimobayashi
MHMichael Hall
Michael Hall

15 January 2016 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
VAVerena Albert
Verena Albert
KSKristoffer Svensson
Kristoffer Svensson
MSMitsugu Shimobayashi
Mitsugu Shimobayashi
MCMarco Colombi
Marco Colombi
SMSergio Muñoz
Sergio Muñoz
MHMichael Hall
Michael Hall
Activation of non‐shivering thermogenesis (NST) in brown adipose tissue (BAT) has been proposed as an anti‐obesity treatment. Moreover, cold‐induced glucose uptake could normalize blood glucose levels in insulin‐resistant patients. It is therefore important to identify novel regulators of NST and cold‐induced glucose uptake. Mammalian target of rapamycin complex 2 (mTORC2) mediates insulin‐stimulated glucose uptake in metabolic tissues, but its role in NST is unknown. We show that mTORC2 is activated in brown adipocytes upon β‐adrenergic stimulation. Furthermore, mice lacking mTORC2 specifically in adipose tissue (AdRiKO mice) are hypothermic, display increased sensitivity to cold, and show impaired cold‐induced glucose uptake and glycolysis. Restoration of glucose uptake in BAT by overexpression of hexokinase II or activated Akt2 was sufficient to increase body temperature and improve cold tolerance in AdRiKO mice. Thus, mTORC2 in BAT mediates temperature homeostasis via regulation of cold‐induced glucose uptake. Our findings demonstrate the importance of glucose metabolism in temperature regulation. Synopsis Albert et al show that β‐adrenergic stimulation activates mTORC2 in brown adipocytes. Active mTORC2 signaling in BAT is required for cold‐induced stimulation of glucose uptake and glycolysis to maintain temperature homeostasis upon cold stress. β‐adrenergic stimulation activates mTORC2 in brown adipocytes. Mice deficient for mTORC2 in adipose tissue are hypothermic and sensitive to cold. mTORC2 in BAT stimulates cold‐induced glucose uptake and glycolysis via Akt. Restoration of glucose uptake in BAT of AdRiKO mice restores temperature homeostasis.

13 March 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AGAsier González
Asier González
MSMitsugu Shimobayashi
Mitsugu Shimobayashi
Tobias EisenbergTobias Eisenberg
Tobias Eisenberg
DMDavid Adrian Merle
David Adrian Merle
TPTobias Pendl
Tobias Pendl
TMTarek Moustafa
Tarek Moustafa
The target of rapamycin complex 1 (TORC1) is an evolutionarily conserved sensor of nutrient availability. Genetic and pharmacological studies in the yeast Saccharomyces cerevisiae have provided mechanistic insights on the regulation of TORC1 signaling in response to nutrients. Using a highly specific antibody that recognizes phosphorylation of the bona fide TORC1 target ribosomal protein S6 (Rps6) in yeast, we found that nutrients rapidly induce Rps6 phosphorylation in a TORC1-dependent manner. Moreover, we demonstrate that Ypk3, an AGC kinase which exhibits high homology to human S6 kinase (S6K), is required for the phosphorylation of Rps6 in vivo. Rps6 phosphorylation is completely abolished in cells lacking Ypk3 (ypk3Δ), whereas Sch9, previously reported to be the yeast ortholog of S6K, is dispensable for Rps6 phosphorylation. Phosphorylation-deficient mutations in regulatory motifs of Ypk3 abrogate Rps6 phosphorylation, and complementation of ypk3Δ cells with human S6 kinase restores Rps6 phosphorylation in a rapamycin-sensitive manner. Our findings demonstrate that Ypk3 is a critical component of the TORC1 pathway and that the use of a phospho-S6 specific antibody offers a valuable tool to identify new nutrient-dependent and rapamycin-sensitive targets in vivo.